Top headlines: Bharat Biotech's Covaxin off trial, IDBI Bank out of PCA

Saudi Aramco's $44-billion refinery project at Nanar in Ratnagiri has become a bone of contention between the Maharashtra government and the Centre

Covaxin, bharat biotech, covid, coronavirus, vaccine, drugs, medicine, pharma
Covaxin was granted restricted use approval in ‘clinical trial mode’ in January by the DCGI
BS Web Team
3 min read Last Updated : Mar 11 2021 | 7:08 AM IST
Covid-19 vaccine: Bharat Biotech's Covaxin goes off clinical trial mode

Bharat Biotech’s Covaxin on Wednesday got the nod from the subject expert committee (SEC), an independent panel set up by the Drugs Controller General of India (DCGI) to advise it, for a restricted emergency use of the Covid-19 vaccine. Covaxin was granted restricted use approval in ‘clinical trial mode’ in January by the DCGI. At that time, the phase 3 trial on 25,800 volunteers was underway. Read more
RBI takes IDBI Bank out of PCA framework after lender improves finances

Private lender IDBI Bank is out of prompt corrective action (PCA) after improving its finances and credit profile, the Reserve Bank of India (RBI) said on Wednesday. This eases the rules for the lender to expand business. This also sets the stage for strategic divestment by the Government of India, which holds 45.48 per cent stake. Read more
BJP, Sena spar over Saudi Aramco's $44-billion refinery project

Oil and gas giant Saudi Aramco's $44-billion refinery project at Nanar in Ratnagiri has become a bone of contention between the Maharashtra government and the Centre, with the Shiv Sena opposing the project and the Modi government pushing to expedite it. Read more
 
India undeterred by Cairn, will defend stand in arbitration row: Sources

India is confident that it can strongly defend its interests if Cairn Energy starts proceedings to enforce a $1.4 billion arbitration award it has won against the country, said official sources on Wednesday, reacting after the company told New Delhi it is identifying for seizure assets belonging to the Indian government in 160 countries. Read more

Adani group set to centre airport business around Mumbai & Ahmedabad

Adani Airports is planning to centre its airport business around Mumbai and Ahme­dabad by developing them as gateway airports, feeding them with traffic from other airports in the company’s portfolio. The Ahmedabad-based conglomerate — with investments in logistics, transportation, utilities and energy — intends to spend Rs 35,000 crore in the airport business in the next five years. Read more
Parliament passes Arbitration Amendment Bill to protect taxpayer money

Parliament on Wednesday approved a Bill to amend the arbitration law that would ensure all stakeholders get a chance to seek an unconditional stay on enforcement of arbitral awards where an agreement is “induced by fraud or corruption”. The Arbitration and Conciliation (Amendment) Bill, 2021, was passed by voice vote in the Rajya Sabha. The Bill was passed in the Lok Sabha on February 12.

It will replace an Ordinance issued on November 4, 2020. Read more

Say cheese: Amul to start making buffalo mozzarella, invest Rs 200 crore

India’s largest dairy cooperative, Amul, has submitted a plan to the government, aiming to turn the country into a global hub for the export of mozzarella cheese made from buffalo milk, which is sold at a hefty premium around the world. Mozzarella cheese is one of the products identified by the government for support under its Rs 10,900 crore production-linked incentive scheme (PLI), to give a massive push to food processing exports. Read more

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :top news of the dayBharat BiotechCoronavirus VaccineIDBI BankBJPShiv SenaCairn EnergyAmulAdani Group

Next Story